We are live on ! Find out more
ZIM

Zacks Investment Management Portfolio holdings

AUM $12.5B
1-Year Est. Return 29.36%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+29.36%
3 Year Est. Return
+98.03%
5 Year Est. Return
+139.15%
10 Year Est. Return
+465.5%
AUM
$4.04B
AUM Growth
+$106M
Cap. Flow
+$157M
Cap. Flow %
3.9%
Top 10 Hldgs %
19.27%
Holding
766
New
131
Increased
235
Reduced
189
Closed
186

Top Buys

Rank Stock Value
1
BBH icon
VanEck Biotech ETF
BBH
+$134M
2
AMGN icon
Amgen
AMGN
+$27M
3
WMB icon
Williams Companies
WMB
+$22.5M
4
XOM icon
ExxonMobil
XOM
+$14.7M
5
AES icon
AES
AES
+$13.6M

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$24.1M
2
CME icon
CME Group
CME
+$22.7M
3
CXT icon
Crane NXT
CXT
+$13.5M
4
AFG icon
American Financial Group
AFG
+$11.8M
5
VZ icon
Verizon
VZ
+$8.71M

Sector Composition

Rank Sector Weight
1 Financials 18.44%
2 Technology 13.83%
3 Industrials 11.98%
4 Healthcare 11.68%
5 Consumer Staples 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSX icon
501
CSX Corp
CSX
$94.5B
$273K 0.01%
+14,988
New +$257K
EXC icon
502
Exelon
EXC
$47.3B
$272K 0.01%
10,577
-948,814
-99% -$24.1M
CBPX
503
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$270K 0.01%
11,584
-2,946
-20% -$71.3K
BGFV
504
DELISTED
Big 5 Sporting Goods
BGFV
$265K 0.01%
20,269
+1,521
+8% +$21.8K
CELG
505
DELISTED
Celgene Corp
CELG
$264K 0.01%
2,029
-41
-2% -$5.02K
KYNB
506
Kyntra Bio
KYNB
$28.3M
$262K 0.01%
324
-290
-47% -$202K
DXC icon
507
DXC Technology
DXC
$1.76B
$261K 0.01%
+3,927
New +$261K
X
508
DELISTED
US Steel
X
$250K 0.01%
11,284
-5,242
-32% -$124K
PLCE icon
509
Children's Place
PLCE
$58.7M
$248K 0.01%
2,429
+48
+2% +$5.27K
POWL icon
510
Powell Industries
POWL
$7.74B
$248K 0.01%
23,277
-5,919
-20% -$65.8K
IBCP icon
511
Independent Bank Corp
IBCP
$792M
$247K 0.01%
11,359
– –
OSK icon
512
Oshkosh
OSK
$9.65B
$247K 0.01%
+3,581
New +$241K
IEX icon
513
IDEX
IEX
$17.5B
$241K 0.01%
+2,130
New +$224K
TSE
514
DELISTED
Trinseo
TSE
$241K 0.01%
3,506
-101
-3% -$6.61K
ISBC
515
DELISTED
Investors Bancorp, Inc.
ISBC
$237K 0.01%
17,710
+3,772
+27% +$51.7K
ADM icon
516
Archer Daniels Midland
ADM
$38.4B
$233K 0.01%
5,631
-618
-10% -$26.5K
ENB icon
517
Enbridge
ENB
$117B
$230K 0.01%
5,784
-4,784
-45% -$193K
ANGO icon
518
AngioDynamics
ANGO
$628M
$229K 0.01%
14,145
-2,450
-15% -$38.7K
SCHG icon
519
Schwab US Large-Cap Growth ETF
SCHG
$62.3B
$226K 0.01%
28,648
+288
+1% +$2.25K
DYN
520
DELISTED
Dynegy, Inc.
DYN
$224K 0.01%
27,114
– –
RDI icon
521
Reading International Class A
RDI
$32.3M
$223K 0.01%
13,833
– –
MSTR icon
522
Strategy Inc
MSTR
$35.7B
$222K 0.01%
+11,580
New +$215K
VYX icon
523
NCR Voyix
VYX
$1.22B
$222K 0.01%
8,849
-71,588
-89% -$1.82M
JBL icon
524
Jabil
JBL
$35.6B
$221K 0.01%
7,578
-53,681
-88% -$1.58M
DLX icon
525
Deluxe
DLX
$1.23B
$219K 0.01%
3,171
-649
-17% -$45.2K
19 20
21
22 23

Similar funds

EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
IMPI
Ilmarinen Mutual Pension Insurance Helsinki, Finland $12.7B AUM 16.27% 1-Year Est. Return
ZIG
Zurich Insurance Group Zurich, Switzerland $12.7B AUM 53.57% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Zacks Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Zacks Investment Management held 766 positions worth $4.04B, up 2.7% from $3.93B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Zacks Investment Management deployed $157M of net new capital in Q2 2017, opening 131 new positions and adding to 235 existing holdings. Its largest new stake was VanEck Biotech ETF: 1,114,205 shares worth $1.12M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Exelon, an estimated $24.1M trimmed.

  • Zacks Investment Management's largest Q2 2017 buy was VanEck Biotech ETF: 1,114,205 shares worth $1.12M.
  • Zacks Investment Management added most to Amgen in Q2 2017, an estimated $27M increase.
  • Zacks Investment Management's biggest Q2 2017 reduction was Exelon, cutting an estimated $24.1M.
  • Zacks Investment Management fully exited Crane NXT in Q2 2017, selling an estimated $13.5M.
  • Zacks Investment Management's ten largest holdings make up 19% of its $4.04B portfolio in Q2 2017.
  • Zacks Investment Management opened 131 new positions and closed 186 in Q2 2017.
  • Zacks Investment Management's portfolio value rose 2.7% quarter-over-quarter to $4.04B.

Based on Zacks Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.